Article
The drug that pleases by paralysis is no reason to party, even in the wake of FDA approval.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
MJH Life Sciences Expands Beauty and Aesthetics Scope With NewBeauty
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
OCT and D-OCT Imaging Reveal Distinct Vascular and Dermal Patterns in Skin Photoaging Phenotypes
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Real-World Study Highlights Burden of Moderate to Severe Atopic Dermatitis in Children and Adolescents
Can Colloidal Oat Emollients Be Used to Treat Pediatric Atopic Dermatitis?
Clinical Trial Validates Delgocitinib’s HRQoL Benefits
Supporting Patients With Rare Genetic Skin Diseases and the Foundations Dedicated to Them
Daily Derm Times: May 5, 2025